D-0258-2022 Class II Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0258-2022 was initiated by Teligent Pharma, Inc. on Oct 19, 2021 and is designated Class II. Reason for recall: Defective Container The recall status is terminated (terminated Jun 18, 2024). Affected quantity: 2664 bottles.

Recall details

Product Type
Drugs
Report Date
Dec 1, 2021
Initiation Date
Oct 19, 2021
Termination Date
Jun 18, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2664 bottles

Product description

Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 52565-002-05

Reason for recall

Defective Container

Distribution pattern

Nationwide within the United States

Code information

Lot #: 15188, Exp 2/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0258-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0258-2022. Report a data issue: hello@regdatalab.com.